News

Press Release

Go to Topics

2021

Sysmex Obtains Manufacturing and Marketing Approval for an Influenza A/B Virus Antigen Detection Test Kit
Influenza can be simultaneously measured in a short period of time in the same the novel coronavirus (SARS-CoV-2) antigen sample using the HISCL™-5000/HISCL-800 Automated Immunoassay Systems - h (PDF:170KB)
Sysmex Receives Approval for a Partial Change to the OncoGuide™ NCC Oncopanel System for Use in Cancer Genome Profiling
- Detection of 10 New Gene Mutations Including MSH6 and PMS2, NTRK3 Gene Fusion and Microsatellite Instability - (PDF:238KB)
Insurance Coverage Received for HISCL™ IFN-λ3 Assay Kit, a Test Kit to Assist in Determining Exacerbation Risk in SARS-CoV-2-Positive Patients (PDF:192KB)
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2021 (PDF:452KB)
Sysmex and Siemens Healthineers Extend Long-standing Global Alliance in Hemostasis Testing (PDF:148KB)
Sysmex Establishes New Subsidiary in Portugal
- Increasing Portuguese Market Presence by Enhancing Sales and After-Sales Support Networks - (PDF:163KB)
Sysmex and Yamato Logistics to Commence GDP-Compliant Transport of Reagents for Gene Testing at the Ultralow Temperature Range of Minus 70 Degrees Celsius or Below
- Also Commencing Experiments for Ultralow Temperature Transport Without Using Dry Ice - (PDF:251KB)
Sysmex Selected as One of the Global 100's Most Sustainable Companies in the World for the Fourth Time (PDF:173KB)
Sysmex and Roche Renew Agreement for Global Alliance
- Transforming a long-standing alliance into one for the next generation - (PDF:145KB)